Articles > Palantir News Update: UK Pushback, Trump's AI Order, Stock Performance, and Analyst Predictions
- British lawmakers are pressuring the UK government to cancel Palantir Technologies' £330 million NHS contract
- President Trump's new AI executive order has raised questions about which company will become a 'Trusted Partner'
- Palantir's stock is sinking due to negative investor sentiment and bearish outlooks
- Despite recent stock performance, Palantir is projected to see growth and has a $250 price target
- Analysts remain divided on Palantir's future success, with some predicting a 60% upside potential
Palantir Technologies is facing backlash in the UK as lawmakers urge the government to reconsider its £330 million NHS contract with the company. The pushback comes as questions are raised about the privacy and security implications of Palantir's involvement in the public sector technology.
President Donald Trump's new AI executive order has introduced a new level of uncertainty for investors, as they speculate on which company, whether it be Microsoft, Oracle, or Palantir, will emerge as a 'Trusted Partner' in Washington's framework for overseeing frontier AI systems.
Investors have been spooked by recent negative sentiments surrounding Palantir's stock, with one well-known investor sharing a bearish outlook. These opinions have contributed to the stock sinking, further adding to the company's challenges.
Despite this, Palantir's stock has seen a notable 12% increase since its last earnings report. With a Strong Buy rating and a $250 price target set for 2027, the company has shown a strong accumulation base and technical momentum that signals further upside potential.
Analysts remain divided on Palantir's future performance, with some predicting a 60% upside potential despite recent stock plunges. The company has demonstrated strong revenue growth and an optimistic outlook, leading to a mix of opinions among industry experts.
As Palantir Technologies continues to navigate challenges both in the UK and in the stock market, investors are closely monitoring the company's trajectory. With conflicting predictions and ongoing scrutiny, Palantir's future remains uncertain, leaving investors speculating on the company's next moves and potential growth.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Palantir News Update: UK Pushback, Trump's AI Order, Stock Performance, and Analyst Predictions
By KlickAnalytics Data Insights | June 3, 2026 08:02PM ET
Key Points
- British lawmakers are pressuring the UK government to cancel Palantir Technologies' £330 million NHS contract
- President Trump's new AI executive order has raised questions about which company will become a 'Trusted Partner'
- Palantir's stock is sinking due to negative investor sentiment and bearish outlooks
- Despite recent stock performance, Palantir is projected to see growth and has a $250 price target
- Analysts remain divided on Palantir's future success, with some predicting a 60% upside potential
Palantir Technologies is facing backlash in the UK as lawmakers urge the government to reconsider its £330 million NHS contract with the company. The pushback comes as questions are raised about the privacy and security implications of Palantir's involvement in the public sector technology.
President Donald Trump's new AI executive order has introduced a new level of uncertainty for investors, as they speculate on which company, whether it be Microsoft, Oracle, or Palantir, will emerge as a 'Trusted Partner' in Washington's framework for overseeing frontier AI systems.
Investors have been spooked by recent negative sentiments surrounding Palantir's stock, with one well-known investor sharing a bearish outlook. These opinions have contributed to the stock sinking, further adding to the company's challenges.
Despite this, Palantir's stock has seen a notable 12% increase since its last earnings report. With a Strong Buy rating and a $250 price target set for 2027, the company has shown a strong accumulation base and technical momentum that signals further upside potential.
Analysts remain divided on Palantir's future performance, with some predicting a 60% upside potential despite recent stock plunges. The company has demonstrated strong revenue growth and an optimistic outlook, leading to a mix of opinions among industry experts.
As Palantir Technologies continues to navigate challenges both in the UK and in the stock market, investors are closely monitoring the company's trajectory. With conflicting predictions and ongoing scrutiny, Palantir's future remains uncertain, leaving investors speculating on the company's next moves and potential growth.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.